Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:2044-2048
Published online before print October 10, 2002, doi: 10.1161/01.ATV.0000040854.47020.44
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
22/12/2044    most recent
01.ATV.0000040854.47020.44v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fang, J. C.
Right arrow Articles by Ganz, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fang, J. C.
Right arrow Articles by Ganz, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Transplantation
Hazardous Substances DB
*NITROGLYCERIN
Related Collections
Right arrow Oxidant stress
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy
Right arrow Other arteriosclerosis
Right arrow Transplantation
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:2044.)
© 2002 American Heart Association, Inc.


Atherosclerosis

Circulating Autoantibodies to Oxidized LDL Correlate With Impaired Coronary Endothelial Function After Cardiac Transplantation

James C. Fang; Scott Kinlay; Dominik Behrendt; Hiroyuki Hikita; Joseph L. Witztum; Andrew P. Selwyn; Peter Ganz

From the Cardiovascular Division (J.C.F., S.K., D.B., H.H., A.P.S., P.G.), Brigham and Women’s Hospital, Boston, Mass, and the Division of Endocrinology and Metabolism (J.L.W.), University of California at San Diego, La Jolla.

Correspondence to James C. Fang, MD, Cardiovascular Division, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115. E-mail jcfang{at}bics.bwh.harvard.edu

Abstract

Objective— The oxidative modification of low density lipoprotein (LDL) may play a role in the pathogenesis of transplant-associated arteriosclerosis. Oxidized LDL (OxLDL) is immunogenic as well as atherogenic, and the level of autoantibodies to OxLDL has been taken as an index of the oxidant state of LDL. Because endothelial dysfunction is key in the initiation of transplant-associated arteriosclerosis, we postulated that the level of OxLDL autoantibody is associated with the degree of impairment of coronary endothelial function.

Methods and Results— Coronary endothelium-dependent dilation was assessed by using intracoronary acetylcholine and endothelium-independent dilation by nitroglycerin in 36 cardiac transplant recipients within 1 year of transplantation. The coronary responses to acetylcholine ranged from -37% (vasoconstriction) to 31% (vasodilation), and the responses to nitroglycerin ranged from 0% to 42% (vasodilation). The coronary vasomotor response to acetylcholine was significantly and inversely related to OxLDL autoantibody levels (r=-0.43, P<0.01) but not LDL levels (r=-0.04, P=0.83) or circulating OxLDL levels detected by monoclonal antibody EO6 (r=-0.27, P=0.11). The coronary artery response to nitroglycerin was not related to levels of OxLDL autoantibodies, LDL, or EO6 (all P=NS).

Conclusions— Autoantibodies to OxLDL are increased in patients with coronary endothelial dysfunction in the first year after cardiac transplantation. The oxidative modification of LDL by inducing endothelial dysfunction in cardiac transplant recipients may be a critical step in the atherogenic effects of LDL and may provide a potential target for therapy.


Key Words: arteriosclerosis • transplantation • endothelium • oxidized LDL




This article has been cited by other articles:


Home page
HypertensionHome page
S. Ashfaq, J. L. Abramson, D. P. Jones, S. D. Rhodes, W. S. Weintraub, W. C. Hooper, V. Vaccarino, R. W. Alexander, D. G. Harrison, and A. A. Quyyumi
Endothelial Function and Aminothiol Biomarkers of Oxidative Stress in Healthy Adults
Hypertension, July 1, 2008; 52(1): 80 - 85.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Junor and K. C. Dellsperger
Can we use surrogate vascular beds for evaluating endothelial function of the coronary vasculature in patients with cardiac allografts?
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H13 - H14.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. H. McNulty, M. A. Tulli, B. J. Robertson, V. Lendel, L. A. Harach, S. Scott, and J. P. Boehmer
Effect of simulated postprandial hyperglycemia on coronary blood flow in cardiac transplant recipients
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H103 - H108.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Shoenfeld, R. Wu, L. D. Dearing, and E. Matsuura
Are Anti-Oxidized Low-Density Lipoprotein Antibodies Pathogenic or Protective?
Circulation, October 26, 2004; 110(17): 2552 - 2558.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. W. Alexander
Oxidized LDL Autoantibodies, Endothelial Dysfunction, and Transplant-Associated Arteriosclerosis
Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 1950 - 1951.
[Full Text] [PDF]